D.E. Shaw & Co’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-262,499	Closed	-$31K	–	4052
2022 Q3	$31K	Hold	262,499	–	–	﹤0.01%	3477
2022 Q2	$26K	Buy	262,499 +175,000	+200%	+$17.3K	﹤0.01%	3784
2022 Q1	$15K	Buy	+87,499	New	+$15K	﹤0.01%	4119